The Economic Burden of Recurrence in Triple-Negative Breast Cancer Among Working Age Patients in the United States.
Jan SielukYan SongJonathan FreimarkMin HuangAmin HaideraliRichard BermanTravis WangJames SignorovitchKim Marie HirshfieldPublished in: Advances in therapy (2021)
The incremental direct and indirect economic burden associated with recurrent TNBC is substantial relative to non-recurrence.